Serial 88841963
Live / Registered — Registered (as of 14 Sept 2021)
What this means for you
Registered since 14 Sept 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 14 Sept 2027, and its filing window is open now).
Record
- Serial number
- 88841963
- Registration number
- 6487272
- Mark type
- Design / logo
- Filed
- 20 Mar 2020
- Published for opposition
- 14 Jul 2020
- Registered
- 14 Sept 2021
- Next maintenance filing
- §8 declaration of use, due by 14 Sept 2027 (grace period to 14 Mar 2028)
- Attorney of record
- Douglas A. Rettew
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for the treatment of Alzheimer's disease
Owner
- Biogen MA Inc., Cambridge, MA, US
- Biogen MA Inc., Cambridge, MA, US
- Biogen MA Inc., Cambridge, MA, US
Prosecution history
- 14 Sept 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Sept 2021 — REGISTERED-PRINCIPAL REGISTER
- 12 Aug 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Aug 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Jul 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Jul 2021 — USE AMENDMENT FILED
- 26 Jul 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Jul 2021 — TEAS STATEMENT OF USE RECEIVED
- 05 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Mar 2021 — SOU EXTENSION 1 GRANTED
- 03 Mar 2021 — SOU EXTENSION 1 FILED
- 03 Mar 2021 — SOU TEAS EXTENSION RECEIVED
- 08 Sept 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 Jul 2020 — POST PUBLICATION AMENDMENT - ENTERED
- 14 Jul 2020 — ASSIGNED TO PETITION STAFF